The result was the discovery of a Chinese company called Kechuang Bio, which Neuralink had never heard of before; Neuralink couldn't even see its taillights.

Hordak, the president of Neuralink, was sweating profusely after being reprimanded by Musk.

Musk is perceived as a passionate and approachable entrepreneur and business leader, but within the company, he is an absolute "tyrant."

Hodak explained, "I'm sorry, but Kechuang Bio may have taken a completely different technological approach than us. I just need a little time to catch up with them."

Musk asked, "Why are we still experimenting on those damn monkeys when brain-computer interfaces for biotechnology have already been successfully commercialized?"

When can we begin human trials?

Neuralink's previous brain-computer interface experiments were conducted on monkeys.

Hordak: "Our human trials have not yet received FDA approval and may take some time."

Musk said helplessly, "Why do we have to conduct our experiments in America? Can't we set up a research and development center in Singapore like Scitech and conduct our experiments in Southeast Asia where the regulations are not so strict?"

Musk has reviewed the information on the biotech company and believes that a key reason why they are ahead of Neuralink is that they started human trials much earlier.

Neuralink has never conducted human trials.

Hodak explained, "Our brain-computer interface is invasive, and the regulations would be much stricter on our approach. Kechuang Bio's brain-computer interface is non-invasive."